Eflucimibe

Overview

Eflucimibe (F 12511) is a new acyl-coenzyme A cholesterol O-acyltransferase ( ACAT ) inhibitor. Eflucimibe can be used in the research of atherosclerosis.

Application

Products | Products > Disease Areas > Cancer | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > Acyltransferase

Product Information

• Catalog No.: HY-19286
• CAS No.: 202340-45-2
• Molecular Formula: C29H43NO2S
• Molecular Weight: 469.72
• Purity: 98.60%
• Storage: Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 6 months , -20°C, 1 month
• Solubility: ≥ 2.5 mg/mL (5.32 mM); Clear solution
• Availability: In-stock

Source

Original product source